Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Background: Alterations in the gut microbiota are strongly associated with the development of inflammatory bowel disease (IBD), particularly with Crohn's disease, which is characterized by reduced abundance of commensal anaerobic bacteria including members of the Bacteroides genus. Our aim was to investigate the protective effects of Bacteroides thetaiotaomicron, an abundant member of this genus, in different rodent models of IBD. Methods: We assessed the effect of B. thetaiotaomicron administration on primary readouts of colitis (weight loss, histopathology, and immune parameters) in dextran sodium sulphate (DSS) and interleukin-10 knockout (IL10KO) models of IBD. Efficacy of a freeze-dried bacterial formulation and a purified recombinant protein of B. thetaiotaomicron was also investigated. Results: B. thetaiotaomicron showed protective effects in both DSS and IL10KO rodent models, as demonstrated by significant amelioration of weight loss, colon shortening, histopathological damage and immune activation. This efficacy was not exclusive to actively growing bacterial preparations but was retained by freeze-dried cells of B. thetaiotaomicron. A pirin-like protein (PLP) of B. thetaiotaomicron, identified by microarray analysis during coculture of the bacterial strain with Caco-2 cells, reduced pro-inflammatory NF-κB signalling in these intestinal epithelial cells. Recombinant PLP partially recapitulated the effect of the whole strain in a rat DSS model. Conclusions: B. thetaiotaomicron displays strong efficacy in preclinical models of IBD and protects against weight loss, histopathological changes in the colon and inflammatory markers. These data indicate that the live strain or its products may be a novel alternative to current treatment options for Crohn's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The enrichment in Bacteroidota can lead to a reduction in intestinal inflammation [18,19,20].”
From A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition (2022) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006) · Gut · doi:10.1136/gut.2005.073817 · Cited by 2,277
Epidemiology and Natural History of Inflammatory Bowel Diseases
Cosnes, J., Gower–Rousseau, C., Seksik, P., & Cortot, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.055 · Cited by 2,211
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
Hooper, L. V., Wong, M. H., Thelin, A., Hansson, L., Falk, P. G., & Gordon, J. I. (2001) · Science · doi:10.1126/science.291.5505.881 · Cited by 2,202
Chemically induced mouse models of acute and chronic intestinal inflammation
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., & Neurath, M. F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.044 · Cited by 1,575
Ott, S. J., Musfeldt, M., Wenderoth, D. F., Hampe, J., Brant, O., Fölsch, U. R., Timmis, K. N., & Schreiber, S. (2004) · Gut · doi:10.1136/gut.2003.025403 · Cited by 1,311
Glycan foraging in vivo by an intestine-adapted bacterial symbiont
Sonnenburg, J. L., Xu, J., Leip, D. D., Chen, C.-H., Westover, B. P., Weatherford, J., Buhler, J. D., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1109051 · Cited by 1,184
Management of Crohn's Disease in Adults
Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.168 · Cited by 1,173
Berg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,136
Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells
Stappenbeck, T. S., Hooper, L. V., & Gordon, J. I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202604299 · Cited by 1,095
A guide to histomorphological evaluation of intestinal inflammation in mouse models.
Erben, U., Loddenkemper, C., Doerfel, K., Spieckermann, S., Haller, D., Heimesaat, M. M., Zeitz, M., Siegmund, B., & Kühl, A. A. (2014) · Europe PMC (PubMed Central) · Cited by 1,052
Kelly, D., Campbell, J. I., King, T. P., Grant, G., Jansson, E. A., Coutts, A. G. P., Pettersson, S., & Conway, S. (2004) · Nature Immunology · doi:10.1038/ni1018 · Cited by 1,003
Self-citationAngiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Baert, F., Moortgat, L., Van Assche, G., Caenepeel, P., Vergauwe, P., De Vos, M., Stokkers, P., Hommes, D., Rutgeerts, P., Vermeire, S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.056 · Cited by 830
Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Barreiro-de Acosta, M., Boberg, K. M., Burisch, J., De Vos, M., De Vries, A.-M., Dick, A. D., et al. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv213 · Cited by 827
A microbial signature for Crohn's disease
Pascal, V., Pozuelo, M., Borruel, N., Casellas, F., Campos, D., Santiago, A., Martinez, X., Varela, E., Sarrabayrouse, G., Machiels, K., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313235 · Cited by 822
Wrzosek, L., Miquel, S., Noordine, M.-L., Bouet, S., Chevalier-Curt, M. J., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., Robbe-Masselot, C., et al. (2013) · BMC Biology · doi:10.1186/1741-7007-11-61 · Cited by 804
Activation of nuclear factor κB in inflammatory bowel disease
Schreiber, S., Nikolaus, S., & Hampe, J. (1998) · Gut · doi:10.1136/gut.42.4.477 · Cited by 750
Experimental Models of Inflammatory Bowel Diseases
Kiesler, P., Fuss, I. J., & Strober, W. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.01.006 · Cited by 713
Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., et al. (2016) · Science · doi:10.1126/science.aad9948 · Cited by 647
Melgar, S., Karlsson, A., & Michaëlsson, E. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2004 · Cited by 578
Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility
Uronis, J. M., Mühlbauer, M., Herfarth, H. H., Rubinas, T. C., Jones, G. S., & Jobin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006026 · Cited by 425
Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
Mähler, M., Bristol, I. J., Leiter, E. H., Workman, A. E., Birkenmeier, E. H., Elson, C. O., & Sundberg, J. P. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.3.g544 · Cited by 401
Resta–Lenert, S., & Barrett, K. E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.015 · Cited by 310
Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
Colombel, J.-F., Narula, N., & Peyrin-Biroulet, L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.046 · Cited by 299
Walters, T. D., Kim, M.-O., Denson, L. A., Griffiths, A. M., Dubinsky, M., Markowitz, J., Baldassano, R., Crandall, W., Rosh, J., Pfefferkorn, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.027 · Cited by 275
Zhou, Y., & Zhi, F. (2016) · BioMed Research International · doi:10.1155/2016/5828959 · Cited by 266
The dextran sulphate sodium (DSS) model of colitis: an overview
Solomon, L., Mansor, S., Mallon, P., Donnelly, E., Hoper, M., Loughrey, M., Kirk, S., & Gardiner, K. (2010) · Comparative Clinical Pathology · doi:10.1007/s00580-010-0979-4 · Cited by 183
Pediatric inflammatory bowel disease
Diefenbach, K. A. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i20.3204 · Cited by 175
Innate immune dysfunction in inflammatory bowel disease
Gersemann, M., Wehkamp, J., & Stange, E. F. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02515.x · Cited by 143
Hoffmann, T. W., Pham, H.-P., Bridonneau, C., Aubry, C., Lamas, B., Martin-Gallausiaux, C., Moroldo, M., Rainteau, D., Lapaque, N., Six, A., et al. (2016) · The ISME Journal · doi:10.1038/ismej.2015.127 · Cited by 138
IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease
Zhu, L., Shi, T., Zhong, C., Wang, Y., Chang, M., & Liu, X. (2017) · Gastroenterology Research · doi:10.14740/gr740w · Cited by 130
Crohn's disease and growth deficiency in children and adolescents
Gasparetto, M., & Guariso, G. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13219 · Cited by 126
Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease
Horowitz, S., Binion, D. G., Nelson, V. M., Kanaa, Y., Javadi, P., Lazarova, Z., Andrekopoulos, C., Kalyanaraman, B., Otterson, M. F., & Rafiee, P. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00499.2006 · Cited by 126
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction.
Zocco, M., Ainora, M., Gasbarrini, G., & Gasbarrini, A. (2007) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.04.003 · Cited by 123
Tadbiri, S., Peyrin‐Biroulet, L., Serrero, M., Filippi, J., Pariente, B., Roblin, X., Buisson, A., Stefanescu, C., Trang‐Poisson, C., Altwegg, R., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14419 · Cited by 116
Pirin is an iron-dependent redox regulator of NF-κB
Liu, F., Rehmani, I., Esaki, S., Fu, R., Chen, L., de Serrano, V., & Liu, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221743110 · Cited by 114
Heterogeneity across the murine small and large intestine
Bowcutt, R., Forman, R. A., Glymenaki, M., Carding, S. R., Else, K. J., & Cruickshank, S. M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15216 · Cited by 111
Chang, Y.-C., Ching, Y.-H., Chiu, C.-C., Liu, J.-Y., Hung, S.-W., Huang, W.-C., Huang, Y.-T., & Chuang, H.-L. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180025 · Cited by 104
Hepatosplenic T-cell lymphoma and inflammatory bowel disease
Thai, A., & Prindiville, T. P. (2010) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2010.05.006 · Cited by 103
SCHEININ, T., BUTLER, D. M., SALWAY, F., SCALLON, B., & FELDMANN, M. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2003.02193.x · Cited by 97
Wang, H., Shi, P., Zuo, L., Dong, J., Zhao, J., Liu, Q., & Zhu, W. (2016) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjw065 · Cited by 70
Beşer, Ö. F., Conde, C. D., Serwas, N. K., Cokugras, F. C., Kutlu, T., Boztuǧ, K., & Erkan, T. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000621 · Cited by 58
Rigoli, L. C., & Caruso, R. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10262 · Cited by 44
Hudcovic, T., Kozáková, H., Kolínská, J., Štěpánková, R., Hrnčíř, T., & Tlaskalová-Hogenová, H. (2009) · Physiological Research · doi:10.33549/physiolres.931340 · Cited by 43
Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD
Shouval, D. S., Konnikova, L., Griffith, A. E., Wall, S. M., Biswas, A., Werner, L., Nunberg, M. Y., Kammermeier, J., Goettel, J. A., Anand, R., et al. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001270 · Cited by 36
Inhibition of arginase ameliorates experimental ulcerative colitis in mice
Akazawa, Y., Kubo, M., Zhang, R., Matsumoto, K., Yan, F., Setiawan, H., Takahashi, H., Fujikura, Y., & Ogino, K. (2012) · Free Radical Research · doi:10.3109/10715762.2012.756980 · Cited by 34
Plasma Osteopontin Predicts Inflammatory Bowel Disease Activities
Komine‐Aizawa, S., Masuda, H., Mazaki, T., Shiono, M., Hayakawa, S., & Takayama, T. (2015) · International Surgery · doi:10.9738/intsurg-d-13-00160.1 · Cited by 28
GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice
Zhao, J., Wang, H., Shi, P., Wang, W., & Sun, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.14210 · Cited by 21
Blotière, P., Rudant, J., Barré, A., Racine, A., Weill, A., Peyrin‐Biroulet, L., Carbonnel, F., & Alla, F. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2016.02.022 · Cited by 20
Osteopontin: Participation in Inflammation or Mucosal Protection in Inflammatory Bowel Diseases?
Chen, F.-Y., Liu, H.-C., Shen, Q., Yuan, S.-Z., Xu, L., Cai, X., Lian, J., & Chen, S.-Y. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2556-y · Cited by 18
Medical management of pediatric inflammatory bowel disease
Baldwin, K. R., & Kaplan, J. L. (2017) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2017.10.005 · Cited by 13
Walters, T. D., & Hyams, J. S. (2014) · Immunotherapy · doi:10.2217/imt.14.57 · Cited by 11
Hughes, P. A., Brierley, S. M., Castro, J., Harrington, A. M., & Blackshaw, L. A. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-095-3_23 · Cited by 1
Cited by
Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues
Lee, M., & Chang, E. B. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.056 · Cited by 645
Mahmud, M. R., Akter, S., Tamanna, S. K., Mazumder, L., Esti, I. Z., Banerjee, S., Akter, S., Hasan, M. R., Acharjee, M., Hossain, M. S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2096995 · Cited by 466
Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease
Clooney, A. G., Sutton, T. D. S., Shkoporov, A. N., Holohan, R. K., Daly, K. M., O’Regan, O., Ryan, F. J., Draper, L. A., Plevy, S. E., Ross, R. P., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.10.009 · Cited by 452
Microbiota‐derived extracellular vesicles in interkingdom communication in the gut
Díaz‐Garrido, N., Badia, J., & Baldomà, L. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12161 · Cited by 405
“thetaiotaomicron have been proved in preclinical models of CD treated with live bacterial suspensions (Delday et al., 2019).”
BackgroundBacteroides utilization for dietary polysaccharides and their beneficial effects on gut health
Cheng, J., Hu, J., Geng, F., & Nie, S. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.04.002 · Cited by 268
Metadata
- Authors
- Delday, M., Mulder, I., Logan, E. T., & Grant, G.
- Affiliations
- University of Aberdeen (GB)
- 4D Pharma Research Ltd, Life Science Innovation Building, Aberdeen, UK
- Corresponding author
- Mulder, Imke
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-09-12
- Volume
- 25
- Issue
- 1
- Pages
- 85-96
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- PMC
- PMC6290787
- OpenAlex
- W2890463030
- Cited by
- 193
- References
- 59
- Citations by year
- 2026: 20 · 2025: 33 · 2024: 32 · 2023: 31 · 2022: 30 · 2021: 22 · 2020: 18 · 2019: 6 · 2018: 1
- FWCI
- 7.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Inflammatory Bowel Diseases (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion, cc-by-nc)
- Funders
- Rural and Environment Science and Analytical Services Division
- Scottish Government
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Bacteroides thetaiotaomicron, Crohn's disease
- MeSH terms
- Bacteroides thetaiotaomicron, Animals, Colitis, Crohn Disease, Disease Models, Animal, Female, Humans, Inflammation, Mice, Inbred C57BL, Dextran Sulfate, Interleukin-10, Mice, Knockout, Caco-2 Cells, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.